Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Aleta Biotherapeutics to Present at Society for Immunotherapy of Cancer


Aleta Biotherapeutics, a privately held immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, today announced a poster presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, to be held in Washington, D.C. and in a virtual platform on November 10-14, 2021.

Full details of the poster presentation are listed below:

Title: Evaluation and development of dual and triple antigen targeting CAR-T Engager proteins for Her2-positive CNS metastases and solid tumors
Presenter: Paul D. Rennert, PhD
Date & Time: Available 7 a.m. EST on Friday, November 12, 2021
Poster Session: Cellular Therapies
Abstract Number: 160

About Aleta Biotherapeutics

Our mission is to create cell therapeutics that provide robust and durable clinical benefit for patients suffering from advanced hematologic cancers and refractory solid tumors. Aleta's CAR-T Engager technology incorporates potent multi-antigen targeting, optimal T cell fitness, and persistence to aggressively attack cancers. We use this technology to build programs that solve specific clinical issues, including cell therapy relapses due to antigen loss and the challenge of overcoming solid tumor heterogeneity. Our lead development program has won landmark clinical support from Cancer Research UK and will enter Phase1/2 trials in 2022. To discover more about our mission, technologies and pipeline please visit www.aletabio.com.


These press releases may also interest you

at 13:15
Biz Apps Partner Summit for Microsoft Ecosystem to Deliver FY 25 Insights
Dynamics Communities and Community Summit North America, in collaboration with Microsoft, are introducing the Biz Apps Partner Summit to run July 24-25, 2024, in Bellevue, Washington delivering a 24-hour immersion into FY 25 priorities, opportunities...

at 13:13
E-Textile Market Size to Grow USD 5238.3 Million by 2029 at a CAGR of 8% | Valuates Reports
E-Textile Market is Segmented by Type (Passive Electronic Textiles, Active Electronic Textiles, Ultra-Electronic Textiles), by Application (Military Uses, Civil Uses, Healthcare Uses). The Global E-Textile Market size is expected to reach USD 5238.3...

at 13:05
Dr. J. Mark Tuthill Joins Gestalt Diagnostics' Strategic Advisory Board
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:57
Hinkal Closes Strategic Funding Round to Advance Discreet Trading and Position Liquidation
Hinkal, a multi-chain privacy layer for confidential decentralized finance (DeFi) transactions, today announced a $1.4 million strategic funding round led by SALT Fund, with participation from Draper Associates, SNZ and Peer VC. Additionally, Tal...

at 12:45
Sogolytics Study Examines Patient Experience Gaps in Telehealth Adoption
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:39
Interfuse Adds New Features to its Knowledge Base
In an effort to provide the best service possible, enterprise developer Interfuse, has added several important improvements to its Knowledge Base application. Within this update, new pages accessible in the Knowledge Base include Recently Added,...

More news about Science and technology...


News published on and distributed by: